Many physicians have limited access to information regarding the teratogenicity of drugs and chemicals, and this information is often highly technical and difficult to interpret to patients. The database consists of a series of agent summaries, each of which is based on a thorough review of published clinical and experimental literature. Summaries may be accessed using either generic names or domestic or foreign proprietary names. Each summary includes a risk assessment derived by consensus of an Advisory Board comprising nationally-recognized authorities in clinical teratology.
Users can access both systems simultaneously.
Together, the two databases provide authoritative clinical teratology information on over 2800 agents.